ATE467628T1 - Benzimidazolverbindungen - Google Patents
BenzimidazolverbindungenInfo
- Publication number
- ATE467628T1 ATE467628T1 AT06731998T AT06731998T ATE467628T1 AT E467628 T1 ATE467628 T1 AT E467628T1 AT 06731998 T AT06731998 T AT 06731998T AT 06731998 T AT06731998 T AT 06731998T AT E467628 T1 ATE467628 T1 AT E467628T1
- Authority
- AT
- Austria
- Prior art keywords
- sup
- sub
- hydrochloric acid
- gastric
- ylmethoxy
- Prior art date
Links
- 150000001556 benzimidazoles Chemical class 0.000 title 1
- 210000004211 gastric acid Anatomy 0.000 abstract 3
- -1 (5,5-dimethyl-1,3-dioxan-2-yl)methoxy, 5,7-dioxaspiro[2.5]oct-6-ylmethoxy, 1,5,9-trioxaspiro[5.5]undec-3-ylmethoxy Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000027119 gastric acid secretion Effects 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 abstract 1
- 239000005977 Ethylene Substances 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 125000004438 haloalkoxy group Chemical group 0.000 abstract 1
- 125000001188 haloalkyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 230000014759 maintenance of location Effects 0.000 abstract 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005117643 | 2005-04-15 | ||
| US67584805P | 2005-04-29 | 2005-04-29 | |
| JP2006008069 | 2006-04-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE467628T1 true ATE467628T1 (de) | 2010-05-15 |
Family
ID=40290731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06731998T ATE467628T1 (de) | 2005-04-15 | 2006-04-17 | Benzimidazolverbindungen |
Country Status (2)
| Country | Link |
|---|---|
| AT (1) | ATE467628T1 (de) |
| MX (1) | MX2007009829A (de) |
-
2006
- 2006-04-17 MX MX2007009829A patent/MX2007009829A/es active IP Right Grant
- 2006-04-17 AT AT06731998T patent/ATE467628T1/de active
Also Published As
| Publication number | Publication date |
|---|---|
| MX2007009829A (es) | 2007-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20072605L (no) | Nytt antranilinsyrederivat eller et salt derav | |
| HRP20040686B1 (hr) | Novi heterocikliäśki spojevi koji djeluju kao inhibitori beta-laktamaza | |
| NO20064032L (no) | DPP-IV inhibitorer | |
| DK2091948T3 (da) | Nye inhibitorer af glutaminylcyclase | |
| WO2011004162A3 (en) | 1, 2, 4-thiazolidin-3-one derivatives and their use in the treatment of cancer | |
| EP1637521A4 (de) | Neue tricyclische heterocyclusverbindung | |
| EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
| PT1261602E (pt) | Derivados imidazol-2-carboxamida como inibidores de cinase raf | |
| UA98966C2 (ru) | Производные бензазепина, пригодные для использования в качестве антагонистов вазопрессина | |
| WO2008146871A1 (ja) | グルココルチコイド受容体結合活性を有する、スルホン酸エステル又はスルホン酸アミド構造を導入したフェニル基を置換基として有する新規１，２，３，４－テトラヒドロキノキサリン誘導体 | |
| TN2010000173A1 (fr) | Antagonistes de cgrp | |
| EP1642880A4 (de) | Proteininhibitoren der hsp90-familie | |
| UA100003C2 (ru) | Соединения 1,2,4,5-тетрагидро-3н-бензазепина, способ их получения и фармацевтическая композиция, которая их содержит | |
| NO20053762L (no) | Kondensert furanforbindelse. | |
| EA200970604A1 (ru) | Новое промежуточное соединение и способ, используемый для получения {2-[1-(3,5-бис-трифторметилбензил)-5-пиридин-4-ил-1н-[1,2,3]триазол-4-ил]пиридин-3-ил}-(2-хлорфенил)метанона | |
| BRPI0511933A (pt) | derivados de quinazolinona úteis como antagonistas de vanilóide | |
| EA200802052A1 (ru) | 2-(пиридин-2-ил)-пиримидины в качестве фунгицидов | |
| EA200601358A1 (ru) | Новые ингибиторы химазы | |
| DE602005002475D1 (de) | Verfahren zur vorbereitung von telithromycin | |
| NO20063268L (no) | Fremgangsmate til fremstilling av 1-(2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-metoksybenzyl)quinuklidin-3-amin | |
| BRPI0608400B8 (pt) | composto 2-(((4-((2,2-dimetil-1,3-dioxan-5-il)metóxi)-3,5-dimetilpiridin-2-il)metil)sulfinil)-1h-benzimidazol ou um sal de metal alcalino do mesmo | |
| ATE491704T1 (de) | 4-ä2-(cycloalkylamino)pyrimidin-4-ylü- (phenyl)imidazolin-2-onderivate als inhibitoren der p38-map-kinase zur behandlung von entzündlichen krankheiten | |
| BR0312586A (pt) | Derivados de pirolidina como antagonistas e oxitocina | |
| WO2007127479A3 (en) | Triaryl substituted imidazole derivatives and taste-inhibiting uses thereof | |
| WO2005005394A3 (en) | Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1870409 Country of ref document: EP |